Aeglea BioTherapeutics
unknown
unknown
Stage
About
Aeglea BioTherapeutics develops engineered human enzymes as novel therapies for rare genetic and metabolic diseases.
Explore Aeglea BioTherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.